Investigating Neighborhood Socioeconomic Status and Acuity of Illness Presentation in Children with Acute Leukemia. Read more about Investigating Neighborhood Socioeconomic Status and Acuity of Illness Presentation in Children with Acute Leukemia.
Examining Disparities By Race, Ethnicity, and Socioeconomic Factors in Children and Young Adults with Relapsed Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group. Read more about Examining Disparities By Race, Ethnicity, and Socioeconomic Factors in Children and Young Adults with Relapsed Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group.
Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States. Read more about Clinician Adherence to Screening and Preventive Practices for Non-Malignant Late Effects Among Allogeneic Hematopoietic Cell Transplant Survivors in the United States.
Structure Guided Design of CCL27 CAR T-Cells Against CCR10 for Multiple Myeloma. Read more about Structure Guided Design of CCL27 CAR T-Cells Against CCR10 for Multiple Myeloma.
Single-Cell Analysis Reveals Depletion of Antigen-Presenting Cell (APC) and IFN-Stimulated CD4 T Cell Populations in High-Risk Newly Diagnosed Multiple Myeloma Patients. Read more about Single-Cell Analysis Reveals Depletion of Antigen-Presenting Cell (APC) and IFN-Stimulated CD4 T Cell Populations in High-Risk Newly Diagnosed Multiple Myeloma Patients.
Novel Single-Cell RNA Technology Simplifies Measurement of Anti-BCMA CAR-Ts in Patient Samples. Read more about Novel Single-Cell RNA Technology Simplifies Measurement of Anti-BCMA CAR-Ts in Patient Samples.
Mitochondrial Priming Is Heterogenous in t(4;14) Multiple Myeloma and Can be Induced By Inhibition of NSD2. Read more about Mitochondrial Priming Is Heterogenous in t(4;14) Multiple Myeloma and Can be Induced By Inhibition of NSD2.
Development of a Dual-Antigen Targeting CAR-T Therapy Directed Against CD70 and Active Integrin ß2 for Acute Myeloid Leukemia. Read more about Development of a Dual-Antigen Targeting CAR-T Therapy Directed Against CD70 and Active Integrin ß2 for Acute Myeloid Leukemia.
Delayed Neurotoxicity after CAR-T in Multiple Myeloma: Results from a Global IMWG Registry. Read more about Delayed Neurotoxicity after CAR-T in Multiple Myeloma: Results from a Global IMWG Registry.
In Vivo and In Vitro Chemical Synthetic Lethality of ABHD17 and MEK Inhibition in NRAS -Mutant Acute Myeloid Leukemia. Read more about In Vivo and In Vitro Chemical Synthetic Lethality of ABHD17 and MEK Inhibition in NRAS -Mutant Acute Myeloid Leukemia.
